Our Product
Symbio develops and manufactures a diverse portfolio of Active Pharmaceutical Ingredients (APIs) and pharmaceutical enzymes, spanning multiple therapeutic areas and complex chemistries. Each product is built on our research-led development engine, emphasizing process optimization, green chemistry, and scalable innovation across our facilities in India.
Our portfolio continues to evolve through strategic collaborations and CDMO partnerships, where we co-develop advanced intermediates, APIs, and enzymes for both regulated and emerging markets. To explore collaboration opportunities or request our detailed product list, please contact symbio@symbiogenerics.com
Symbio Vizag
Ursodeoxycholic Acid (US DMF)
Tauro-Ursodeoxycholic Acid
Nor-Ursodeoxycholic Acid
Edoxaban
Empagliflozin (US DMF)
Minoxidil (US DMF)
Oxcarbazepine (US DMF)
Verapamil
Finerenone
Vonoprazan
Resmetirom
VPL Chemical
Minoxidil (CEP)
Eslicarbazepine
Fexofenadine
Ambroxol
Pregabalin
Symbio Tumakuru
Valganciclovir
Pancreatin IP/USP/Ph Eur
Trypsin Chymotrypsin
Trypsin BP
Alpha Chymotrypsin
Ox Bile
Pepsin IP
Rutoside Trihydrate BP
Pellets & Granules
Pancreatin Pellets
Pancreatin Granules
Trypsin - Bromelain - Rutoside
Alpha Lipoic Acid Granules 80%
Alpha Lipoic Acid Pellets 60%
Trypsin Chymotrypsin E.C. Granules
Orlistat Pellets
Serratiopeptidase E.C. Granules
Dabigatran Pellets
CMO Facility
CoEnzyme Q10
Chondroitin Sulphate
Levocarnitine
Glucosamine
L-Carnitine L-Tartrate
India Market Products
Montelukast
Rocuronium Bromide
Dydrogesterone
Tranexamic Acid IP
Alpha Lipoic Acid IP
Bromelain 2400GDU
Enoxaparin Sodium IP/USP
Heparin Sodium IP
Acarbose IP
Tofacitinib Citrate IP
Lactulose IP/USP/BP/Ph Eur
Sitagliptin IP
Tacrolimus IP/USP
Mifepristone IP
Product Pipeline
Semaglutide
Tegoprazan
Ferric Carboxymaltose
Eltrombopag
Avatrombopag
Mycophenolate Mofetil
Mycophenolate Sodium